You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
About the Therapy
Deep brain stimulation (DBS) therapy may reduce many of the symptoms of Parkinson's disease.1 This adjustable and if necessary, reversible therapy uses an implanted device that electrically stimulates the brain, blocking the signals that cause disabling motor symptoms.
DBS therapy for Parkinson's disease uses a surgically implanted medical device similar to a cardiac pacemaker to deliver electrical stimulation to precisely targeted areas within the brain.
All treatment and outcome results are specific to the individual patient, and will form part of your consultation with your healthcare professional.
Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to DBS therapy.
Learn some of the commonly asked questions and concerns about how DBS therapy may reduce the symptoms of Parkinson's disease.
Deep brain stimulation (DBS) therapy is a surgical treatment which may reduce some of the symptoms associated with Parkinson's disease (PD).1
DBS uses a surgically implanted medical device similar to a cardiac pacemaker to deliver electrical stimulation to precisely targeted areas within the brain.
Stimulation of these areas blocks the signals that cause the disabling motor symptoms of Parkinson's disease. The electrical stimulation can be noninvasively adjusted to maximise therapy benefits. As a result, many individuals may achieve greater control over their body movements.
A DBS system consists of three implanted components:
Your surgeon will provide you with a small handheld patient programmer. This programmer lets you turn the system on and off by holding it for 1 or 2 seconds against the area where the neurostimulator is implanted. However, in most cases, the neurostimulator is always on.
DBS offers an adjustable and if necessary, reversible method for the treatment of the symptoms of Parkinson's disease (PD).
DBS uses a surgically implanted medical device similar to a cardiac pacemaker to deliver electrical stimulation to the parts of the brain that control movement. Stimulation of these areas blocks the signals that cause the disabling motor symptoms of Parkinson's disease. As a result, individuals may achieve greater control over their body movements.
The DBS system consists of three implanted components:
The device settings and stimulation levels can be adjusted noninvasively by a clinician using a programming device.
Although there is no cure for Parkinson's disease, DBS may reduce some of the symptoms associated with Parkinson's disease.1
Risks of DBS can include risks of surgery, side effects, or device complications. Please see Benefits and Risks for more details.
Neurologists and neurosurgeons have used electrical stimulation since the 1960s as a way to locate and distinguish specific sites in the brain. Brain stimulation technology was developed in the 1980s.
There is no cure for Parkinson's disease at this time. DBS therapy may reduce some of the symptoms of Parkinson's disease1, but does not cure the underlying condition. If the therapy is discontinued, your symptoms will return.
DBS therapy reduces complications of drug therapy, such as dyskinesia and fluctuations in 'on' and 'off' time. It reduces complications of drug therapy by 37% and troublesome side effects are reduced by 61% compared to medication alone. Without DBS, people receiving best medical therapy (BMT) experience between a 5.4% reduction to a 13% increase in drug-related complications compared with their baseline1,2,3,4.
Okun MS, Fallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant current device in Parkinson’s disease: an open label randomized clinical trial. Lancet Neurology. 2012;11(12):1014-1015.
Schüpbach W, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. EARLYSTIM Study. N Eng J Med. 2013;368:610-622.
Weaver FM, Follett KA, Stern M, et al. Bilateral deep brain stimulation vs. best medical therapy for patients with advanced Parkinson’s disease. JAMA. 2009;301(1):63-73.
Williams A, Gill S, Jenkinson C, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD Surg trial): a randomised, open-label trial. Lancet Neurology 2010;9(6):581-91.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.